Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Carriage of Methicillin-resistant Staphylococcus aureus in a Colony of Rhesus (Macaca mulatta) and Cynomolgus (Macaca fascicularis) Macaques.

Greenstein AW, Boyle-Vavra S, Maddox CW, Tang X, Halliday LC, Fortman JD.

Comp Med. 2019 Aug 2. doi: 10.30802/AALAS-CM-18-000089. [Epub ahead of print]

PMID:
31375150
2.

Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.

Lee H, Boyle-Vavra S, Ren J, Jarusiewicz J, Sharma LK, Hoagland DT, Yin S, Zhu T, Hevener KE, Ojeda I, Lee RE, Daum RS, Johnson ME.

Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593-18. doi: 10.1128/AAC.02593-18. [Epub ahead of print]

PMID:
31209003
3.

Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.

Luna BM, Nielsen TB, Cheng B, Pantapalangkoor P, Yan J, Boyle-Vavra S, Bruhn KW, Montgomery C, Spellberg B, Daum R.

PLoS One. 2019 Jun 10;14(6):e0217439. doi: 10.1371/journal.pone.0217439. eCollection 2019.

4.

Can Methicillin-resistant Staphylococcus aureus Silently Travel From the Gut to the Wound and Cause Postoperative Infection? Modeling the "Trojan Horse Hypothesis".

Krezalek MA, Hyoju S, Zaborin A, Okafor E, Chandrasekar L, Bindokas V, Guyton K, Montgomery CP, Daum RS, Zaborina O, Boyle-Vavra S, Alverdy JC.

Ann Surg. 2018 Apr;267(4):749-758. doi: 10.1097/SLA.0000000000002173.

PMID:
28187042
5.

Staphylococcal SCCmec elements encode an active MCM-like helicase and thus may be replicative.

Mir-Sanchis I, Roman CA, Misiura A, Pigli YZ, Boyle-Vavra S, Rice PA.

Nat Struct Mol Biol. 2016 Oct;23(10):891-898. doi: 10.1038/nsmb.3286. Epub 2016 Aug 29.

6.

Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans.

Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS.

J Immunol. 2016 Aug 15;197(4):1118-26. doi: 10.4049/jimmunol.1600549. Epub 2016 Jul 11.

7.

Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections.

Azarian T, Daum RS, Petty LA, Steinbeck JL, Yin Z, Nolan D, Boyle-Vavra S, Hanage WP, Salemi M, David MZ.

J Infect Dis. 2016 Sep 15;214(6):895-905. doi: 10.1093/infdis/jiw242. Epub 2016 Jun 10.

8.

Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection.

Zhao F, Cheng BL, Boyle-Vavra S, Alegre ML, Daum RS, Chong AS, Montgomery CP.

Infect Immun. 2015 Sep;83(9):3712-21. doi: 10.1128/IAI.00667-15. Epub 2015 Jul 13.

9.

Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.

David MZ, Acree ME, Sieth JJ, Boxrud DJ, Dobbins G, Lynfield R, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2015 Aug;53(8):2486-91. doi: 10.1128/JCM.00096-15. Epub 2015 May 27.

10.

Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.

Gaupp R, Lei S, Reed JM, Peisker H, Boyle-Vavra S, Bayer AS, Bischoff M, Herrmann M, Daum RS, Powers R, Somerville GA.

Antimicrob Agents Chemother. 2015 Jul;59(7):4226-38. doi: 10.1128/AAC.00160-15. Epub 2015 May 11.

11.

USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus.

Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J, Cywes-Bentley C, Dobbins G, David MZ, Kumar N, Eells SJ, Miller LG, Boxrud DJ, Chambers HF, Lynfield R, Lee JC, Daum RS.

MBio. 2015 Apr 7;6(2). pii: e02585-14. doi: 10.1128/mBio.02585-14.

12.

Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.

Alam MT, Read TD, Petit RA 3rd, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ.

MBio. 2015 Mar 10;6(2):e00054. doi: 10.1128/mBio.00054-15.

13.

High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department.

Kumar N, David MZ, Boyle-Vavra S, Sieth J, Daum RS.

J Clin Microbiol. 2015 Mar;53(3):810-5. doi: 10.1128/JCM.03221-14. Epub 2014 Dec 24.

14.

Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains.

Jones MB, Montgomery CP, Boyle-Vavra S, Shatzkes K, Maybank R, Frank BC, Peterson SN, Daum RS.

BMC Genomics. 2014 Dec 19;15:1145. doi: 10.1186/1471-2164-15-1145.

15.

Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors.

Miller LG, Eells SJ, David MZ, Ortiz N, Taylor AR, Kumar N, Cruz D, Boyle-Vavra S, Daum RS.

Clin Infect Dis. 2015 Mar 1;60(5):753-63. doi: 10.1093/cid/ciu943. Epub 2014 Nov 26.

16.

A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Porsa E, Schumm LP, Boyle-Vavra S, Daum RS.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1466-73. doi: 10.1086/678606.

PMID:
25419768
17.

Persistent environmental contamination with USA300 methicillin-resistant Staphylococcus aureus and other pathogenic strain types in households with S. aureus skin infections.

Eells SJ, David MZ, Taylor A, Ortiz N, Kumar N, Sieth J, Boyle-Vavra S, Daum RS, Miller LG.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1373-82. doi: 10.1086/678414. Epub 2014 Sep 22.

PMID:
25333432
18.

Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Taylor AR, Zychowski DL, Porsa E, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2014 Sep;52(9):3422-5. doi: 10.1128/JCM.01190-14. Epub 2014 Jun 23.

19.

Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections.

David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG Jr, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B.

Clin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30.

20.

Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008.

David MZ, Cadilla A, Boyle-Vavra S, Daum RS.

PLoS One. 2014 Apr 22;9(4):e92760. doi: 10.1371/journal.pone.0092760. eCollection 2014.

21.

The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.

Qureshi NK, Yin S, Boyle-Vavra S.

PLoS One. 2014 Jan 15;9(1):e85873. doi: 10.1371/journal.pone.0085873. eCollection 2014.

22.

Asymptomatic carriage of sequence type 398, spa type t571 methicillin-susceptible Staphylococcus aureus in an urban jail: a newly emerging, transmissible pathogenic strain.

David MZ, Siegel J, Lowy FD, Zychowski D, Taylor A, Lee CJ, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2013 Jul;51(7):2443-7. doi: 10.1128/JCM.01057-13. Epub 2013 May 8.

23.

Roles of two large serine recombinases in mobilizing the methicillin-resistance cassette SCCmec.

Misiura A, Pigli YZ, Boyle-Vavra S, Daum RS, Boocock MR, Rice PA.

Mol Microbiol. 2013 Jun;88(6):1218-29. doi: 10.1111/mmi.12253. Epub 2013 May 23.

24.
25.

VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.

Boyle-Vavra S, Yin S, Jo DS, Montgomery CP, Daum RS.

Antimicrob Agents Chemother. 2013 Jan;57(1):83-95. doi: 10.1128/AAC.01651-12. Epub 2012 Oct 15.

26.

Guidelines for reporting novel mecA gene homologues.

Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM, Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF Jr, Daum R, Soderquist B, Buist G; International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC).

Antimicrob Agents Chemother. 2012 Oct;56(10):4997-9. Epub 2012 Aug 6. No abstract available.

27.

CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300.

Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS.

Infect Immun. 2012 Jul;80(7):2382-9. doi: 10.1128/IAI.06172-11. Epub 2012 Apr 23.

28.

Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology.

Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS.

Clin Infect Dis. 2012 Jun;54(11):1523-35. doi: 10.1093/cid/cis213. Epub 2012 Apr 3.

29.

MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006.

David MZ, Rudolph KM, Hennessy TW, Zychowski DL, Asthi K, Boyle-Vavra S, Daum RS.

Emerg Infect Dis. 2012 Jan;18(1):105-8. doi: 10.3201/eid1801.110746.

30.

Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles?

David MZ, Boyle-Vavra S, Zychowski DL, Daum RS.

PLoS One. 2011 Apr 13;6(4):e18217. doi: 10.1371/journal.pone.0018217.

31.

Universal admission screening for methicillin-resistant Staphylococcus aureus in a level IIID neonatal intensive care unit: the first 9 months.

Myers PJ, Marcinak J, David MZ, Zychowski DL, Boyle-Vavra S, Weber S, Daum RS.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):398-400. doi: 10.1086/659153. No abstract available.

PMID:
21460494
32.

Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion.

Jo DS, Montgomery CP, Yin S, Boyle-Vavra S, Daum RS.

Antimicrob Agents Chemother. 2011 Jun;55(6):2818-23. doi: 10.1128/AAC.01704-10. Epub 2011 Mar 7.

33.

Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure.

Boyle-Vavra S, Jones M, Gourley BL, Holmes M, Ruf R, Balsam AR, Boulware DR, Kline S, Jawahir S, Devries A, Peterson SN, Daum RS.

Antimicrob Agents Chemother. 2011 May;55(5):2018-25. doi: 10.1128/AAC.01593-10. Epub 2011 Feb 22.

34.

Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection.

Montgomery CP, Boyle-Vavra S, Daum RS.

PLoS One. 2010 Dec 2;5(12):e15177. doi: 10.1371/journal.pone.0015177.

35.

Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.

Cadilla A, David MZ, Daum RS, Boyle-Vavra S.

J Clin Microbiol. 2011 Jan;49(1):95-100. doi: 10.1128/JCM.00759-10. Epub 2010 Nov 17.

36.
37.
38.

Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

Crawford SE, David MZ, Glikman D, King KJ, Boyle-Vavra S, Daum RS.

J Am Board Fam Med. 2009 Nov-Dec;22(6):647-54. doi: 10.3122/jabfm.2009.06.090025.

40.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska.

David MZ, Rudolph KM, Hennessy TW, Boyle-Vavra S, Daum RS.

Emerg Infect Dis. 2008 Nov;14(11):1693-9. doi: 10.3201/eid1411.080381.

41.

Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates.

David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2008 Oct;46(10):3222-7. doi: 10.1128/JCM.01423-08. Epub 2008 Aug 6.

42.

Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia.

Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS.

J Infect Dis. 2008 Aug 15;198(4):561-70. doi: 10.1086/590157. Erratum in: J Infect Dis. 2008 Dec 1;198(11):1725.

PMID:
18598194
43.

What is community-associated methicillin-resistant Staphylococcus aureus?

David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS.

J Infect Dis. 2008 May 1;197(9):1235-43. doi: 10.1086/533502.

PMID:
18422435
44.

Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus.

Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, Daum RS.

Chest. 2008 Jun;133(6):1381-1387. doi: 10.1378/chest.07-2437. Epub 2008 Mar 17.

PMID:
18347206
45.

Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections.

Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG.

Emerg Infect Dis. 2007 Feb;13(2):236-42.

46.

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.

Boyle-Vavra S, Daum RS.

Lab Invest. 2007 Jan;87(1):3-9. Epub 2006 Dec 4. Review.

48.

Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates.

David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS.

Emerg Infect Dis. 2006 Apr;12(4):631-7.

49.
50.

Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children.

Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, Boyle-Vavra S, Daum RS.

N Engl J Med. 2005 Sep 22;353(12):1245-51.

Supplemental Content

Loading ...
Support Center